ProfileGDS4718 / 236415_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 42% 40% 36% 42% 37% 37% 41% 45% 37% 37% 41% 36% 41% 42% 36% 40% 41% 50% 37% 49% 42% 38% 37% 43% 39% 39% 39% 38% 45% 44% 42% 39% 42% 38% 41% 37% 39% 41% 41% 39% 44% 40% 34% 36% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.1110642
GSM549102patient 115, normal, homogenized [OPG study]5.0350340
GSM549104patient 119, normal, homogenized [OPG study]4.7889536
GSM549108patient 138, normal, homogenized [OPG study]5.1324942
GSM549119patient 077, normal, homogenized [OPG study]4.8504337
GSM549133patient 032, cancer, homogenized [OPG study]4.7880537
GSM549139patient 042, cancer, homogenized [OPG study]5.0037341
GSM549099patient 107, normal, homogenized [OPG study]5.2809345
GSM549109patient 139, normal, homogenized [OPG study]4.8762537
GSM549110patient 046, normal, homogenized [OPG study]4.8367137
GSM549114patient 063, normal, homogenized [OPG study]4.9784841
GSM549122patient 082, normal, homogenized [OPG study]4.8303636
GSM549134patient 033, cancer, homogenized [OPG study]5.0429141
GSM549136patient 036, cancer, homogenized [OPG study]5.0095542
GSM549140patient 044, cancer, homogenized [OPG study]4.7709536
GSM549111patient 047, normal, homogenized [OPG study]4.9646540
GSM549113patient 057, normal, homogenized [OPG study]5.0009641
GSM549132patient 031, cancer, homogenized [OPG study]5.4865450
GSM549137patient 038, cancer, homogenized [OPG study]4.8310437
GSM549142patient 047, cancer, homogenized [OPG study]5.5980149
GSM549100patient 110, normal, homogenized [OPG study]5.1096342
GSM549107patient 135, normal, homogenized [OPG study]4.8482638
GSM549115patient 068, normal, homogenized [OPG study]4.7958737
GSM549116patient 072, normal, homogenized [OPG study]5.1350243
GSM549120patient 078, normal, homogenized [OPG study]4.9560539
GSM549131patient 030, cancer, homogenized [OPG study]4.8737239
GSM549118patient 074, normal, homogenized [OPG study]4.9538739
GSM549129patient 027, cancer, homogenized [OPG study]4.9260338
GSM549123patient 088, normal, homogenized [OPG study]5.2105145
GSM549124patient 006, cancer, homogenized [OPG study]5.2413944
GSM549126patient 015, cancer, homogenized [OPG study]5.0665742
GSM549128patient 025, cancer, homogenized [OPG study]4.9059639
GSM549103patient 117, normal, homogenized [OPG study]5.1314142
GSM549117patient 073, normal, homogenized [OPG study]4.8710138
GSM549138patient 041, cancer, homogenized [OPG study]5.0341
GSM549141patient 045, cancer, homogenized [OPG study]4.7670937
GSM549130patient 028, cancer, homogenized [OPG study]4.9256839
GSM549101patient 111, normal, homogenized [OPG study]5.0626541
GSM549105patient 128, normal, homogenized [OPG study]5.0398241
GSM549106patient 134, normal, homogenized [OPG study]4.893139
GSM549112patient 048, normal, homogenized [OPG study]5.1568544
GSM549125patient 011, cancer, homogenized [OPG study]5.0157840
GSM549127patient 024, cancer, homogenized [OPG study]4.7260134
GSM549135patient 035, cancer, homogenized [OPG study]4.7703736